Evidence map›Paper›PMID 25074391›Full record

ArticleEuropean journal of clinical nutrition2015

Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents.

P Li, R Jiang, L Li, C Liu, F Yang, Y Qiu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Effect of Genetic Variations in theDiabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  9. Article
  10. Article
  11. Polymorphism Of TheDiabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  12. The Relationship of adiponectin level andDermato-endocrinology · 2018
    Article
  13. Article
  14. Hypoadiponectemia is associated with metabolic syndrome in patients with type 2 diabetes.International journal of clinical and experimental pathology · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

P LiDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China.
R JiangLiaoyang Diabetes Hospital, Liaoyang, PR China.
L Li1] Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China [2] The Liaoning Provincial Key Laboratory of Endocrine Diseases, Shenyang, PR China.
C LiuDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China.
F YangDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China.
Y QiuDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China.
China Medical University · CNThird People 's Hospital of Liaoyang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesTo investigate the association of adiponectin and its gene polymorphisms with metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors in Chinese adolescents. SUBJECTS/

methodsThis cross-sectional study enrolled 919 healthy middle school students (aged 11-16 years; 46.7% females). All participants underwent anthropometric and biochemical examinations, and MetS was diagnosed using 2007 International Diabetes Federation criteria. The presence of adiponectin and its genotypes of single nucleotide polymorphisms (SNPs) rs266729 (-11377C/G), rs2241766 (+45T/G) and rs1501299 (+276G/T) was detected.

results(1) Serum adiponectin levels were negatively correlated with numerous CVD risk factors (all P<0.05), and following adjustments for confounding factors, a lower adiponectin level was an independent risk factor for MetS (odds ratio=5.59; 95% confidence interval: 1.90, 16.41). Central obesity and low levels of high-density lipoprotein cholesterol were positively associated with MetS and reduced serum adiponectin levels. (2) The genotype and frequencies of SNP-11377 and SNP+276 in a MetS group and non-MetS group were not significantly different. Subjects with genotype SNP+45 GG were at higher risk for MetS compared with subjects with genotypes SNP+45 TT (P=0.033) or TT+TG (P=0.021). Subjects with genotype SNP+276 TT or TT+TG had higher levels of serum adiponectin compared with subjects with SNP+276 GG (P=0.012 and 0.014, respectively).

conclusionsAdiponectin may be used as a predictive biomarker of MetS, and shows a significant association with CVD risk factors in Chinese adolescents. Adiponectin gene polymorphisms are associated with serum adiponectin concentrations and the presence of MetS.

Indexed as

AdiponectinAdolescentCardiovascular DiseasesChildChinaCross-Sectional StudiesFemaleGenotypeHumansLipidsMaleMetabolic SyndromeObesityPolymorphism, Single NucleotideRisk FactorsAdiponectinLipids

Identifiers

PMID25074391
OpenAlexW2022913455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.